Peripheral Serotonin and Albinism

Recruiting Observational Study
Oculocutaneous Albinism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 – 17
Sex
Any
Study type
Observational
Participants needed
160 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Serotonin (5-HT or 5-hydroxytryptamine) is a monoamine primarily known for its role as a neurotransmitter in the central nervous system (CNS). However, the functions of serotonin go beyond its role in the central nervous system: different peripheral tissues have the capacity to produce and/or use serotonin locally, forming systems called "micro-serotonergic" systems. Among the peripheral roles of …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients: * Patients with albinism aged 2 to 17 years * Followed in the MAGEC-Necker reference center (reference center for rare diseases of the skin and mucous membranes of genetic origin), during the inclusion period * Information of parental authority holders of patients and…
Contacts

Smail HADJ-RABIA, MD, PhD

1 44 49 46 62

smail.hadjrabia@aphp.fr

CONTACT

Hélène Morel

1 44 38 16 53

helene.morel@aphp.fr

CONTACT